{"id":11385492,"date":"2025-09-28T19:58:00","date_gmt":"2025-09-28T16:58:00","guid":{"rendered":"https:\/\/nostylelike.net\/?post_type=product&p=11385492"},"modified":"2026-05-13T01:27:49","modified_gmt":"2026-05-12T22:27:49","slug":"ibrance","status":"publish","type":"product","link":"https:\/\/nostylelike.net\/en\/product\/ibrance\/","title":{"rendered":"IBRANCE (Palbociclib) 75 mg & 125 mg Capsules \u2013 Breast Cancer Treatment HR+\/HER2"},"content":{"rendered":"
\n

<\/p>\n

IBRANCE (Palbociclib) 75 mg & 125 mg Capsules \u2013 Breast Cancer Treatment HR+\/HER2-<\/h2>\n

<\/p>\n

IBRANCE (Palbociclib)<\/strong> by Pfizer<\/strong> is indicated for HR-positive, HER2-negative advanced or metastatic breast cancer. As a CDK4\/6 inhibitor, it slows cancer cell growth and is commonly prescribed with endocrine therapy such as Letrozole or Fulvestrant to improve treatment outcomes.<\/div>\n

<\/p>\n

<\/p>\n\n\n\n\n\n\n\n\n\n\n
Name<\/th>\nIBRANCE (Palbociclib) 75 mg & 125 mg<\/td>\n<\/tr>\n
Brand<\/th>\nPfizer<\/td>\n<\/tr>\n
Strength<\/th>\n75 mg \/ 125 mg<\/td>\n<\/tr>\n
Form<\/th>\nFilm-coated Capsules<\/td>\n<\/tr>\n
Quantity \/ Size<\/th>\nBox of 21 capsules<\/td>\n<\/tr>\n
Manufacturer<\/th>\nPfizer<\/td>\n<\/tr>\n
Country of Origin<\/th>\nUSA<\/td>\n<\/tr>\n
Product Code<\/th>\nIBR-75\/125-PFZ<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/p>\n

Uses and Benefits<\/h2>\n

IBRANCE (Palbociclib)<\/strong> is indicated for the treatment of HR-positive, HER2-negative<\/strong> advanced or metastatic breast cancer in combination with endocrine therapy. As a selective CDK4\/6 inhibitor<\/strong>, it blocks proteins that drive cell cycle progression, thereby slowing tumor growth and delaying disease progression.<\/p>\n